MPE has received funding from the following sources in 2023 and 2024:
Industry supporters
- AbbVie
- Amgen
- Alexion
- AstraZeneca
- BeiGene
- Binding Site
- Bristol Myers Squibb
- GlaxoSmithKline
- Janssen
- Kite, A Gilead Company
- Novartis
- Oncopeptides
- Pfizer
- Regeneron
- Roche
- Sanofi
- Menarini Stemline
- Takeda
- Sebia
- Prothena
- SkylineDx
- Sandoz
Public supporters
Horizon Europe
Innovative Medicine Initiative (IMI)
- Horizon 2020 CARAMBA
- Horizon Europe ASCERTAIN
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 754658.
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101094938.
- IMI HARMONY
- SISAQOL IMI
You can freely download the funding sources reports by clicking on the links below:
